Vaccine Induced Immunity
Vaccine Induced Immunity - Related Videos
08:18
Evaluation of Vaccine-Induced Immunity Against Bacterial Infection in a Mouse Model
0 Views •
2025
In this video, we describe a protocol to test the efficacy of an acellular pertussis vaccine against Bordetella pertussis infection in mice. Post-vaccination, the mice were subjected to infection, and their tissue homogenate was cultured to analyze the bacterial colonies as a readout of the vaccine-induced protective immunity.
01:51
Vaccinations
0 Views •
2019
Overview Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
0 Views •
Cited by 1 •
2015
There is an overall lack of knowledge about how vaccines work. Here we propose the combined use of reverse genetics and bone marrow chimeric mice to gain insight into the early host immune responses to vaccines with a special focus on dendritic cells and T cell immunity.
04:10
A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies
0 Views •
2024
Here, we present a protocol to demonstrate safe, trap-vaccinate-release (TVR) techniques for carnivores susceptible to rabies.
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
0 Views •
Cited by 18 •
2014
Prophylactic and therapeutic vaccination often fails to stimulate strong immune responses due to week drainage of the vaccine to lymph nodes and consequently poor involvement of immune cells. By direct injection of vaccine to lymph nodes, so-called intralymphatic injection, vaccine efficacy can be strongly improved and vaccine doses can be reduced.
FAQs
B lymphocytes support antibody production, providing a targeted response to a recognized pathogen. T lymphocytes contribute to adaptive immune coordination and are part of the memory response established after vaccination. Together, these cell populations help the immune system respond more rapidly during later exposure, which can reduce disease severity and, depending on the vaccine and pathogen, infection or transmission.
Vaccines can present antigens directly or provide genetic instructions that lead the body to recognize a pathogen-related target. In either case, the stimulus engages adaptive immune responses and supports antibody production and memory-cell formation. This shared outcome allows different vaccine designs to train immune recognition without causing the targeted disease described in the overview.
Protection is not identical in every setting because effectiveness depends on the particular vaccine, the pathogen it targets, and characteristics of the host. These differences influence how well vaccination reduces infection, disease severity, or transmission. Consequently, evidence for one vaccine or pathogen should not automatically be applied to another, and medical guidance may account for these distinctions.
Booster strategies are used to reinforce protection when additional vaccination is appropriate. They build on the immune system’s prior training and can support the established antibody and memory-cell response. Their use is therefore linked to maintaining or strengthening protection rather than introducing the basic concept of vaccination, and the appropriate strategy depends on the vaccine, pathogen, and host.
Researchers can assess whether vaccination reduces infection, limits disease severity, or lowers transmission after later exposure to a pathogen. These outcomes reflect different dimensions of protection, so a vaccine may be evaluated beyond whether infection occurs at all. Such measurements help characterize effectiveness and inform decisions about prevention strategies, including whether booster approaches may be relevant.
At the population level, high vaccination coverage can contribute to protection beyond the directly vaccinated individuals by helping reduce the spread of infectious diseases. This makes vaccination a medical prevention strategy as well as an individual immune intervention. Coverage therefore matters when public-health planners consider disease prevention, transmission reduction, and the broader effects of vaccination programs.